奥德赛制药 ODTX
$19.23 +$0.35 (+1.85%)
休市 · Nov 8, 7:00 am ET · 最新盘后价 $19.23 0.00%
开盘$18.99
昨收$18.88
当日区间$18.01 – $19.70
成交量577.3K
市值$924.35M
市盈率（TTM）–
股息率–
ODTX 相关新闻
匹配 Odyssey Therapeutics 或代码 ODTX 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Keeps Their Buy Rating on Odyssey Therapeutics, Inc. (ODTX)
- Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)
- Wedbush Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $30
- H.C. Wainwright Initiates Odyssey Therapeutics(ODTX.US) With Buy Rating, Announces Target Price $44
- TD Cowen Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating
- Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Metagenomi, Inc. (MGX) and Autolus Therapeutics (AUTL)
- J.P. Morgan Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Raises Target Price to $29 正面
- A Quick Look at Today's Ratings for Odyssey Therapeutics(ODTX.US), With a Forecast Between $16.96 to $40
- Analysts Offer Insights on Healthcare Companies: Odyssey Therapeutics, Inc. (ODTX), Capricor Therapeutics (CAPR) and Medtronic (MDT)
- Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40
- Oppenheimer Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $40
- Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and Odyssey Therapeutics, Inc. (ODTX)
- UBS Maintains Odyssey Therapeutics(ODTX.US) With Buy Rating, Maintains Target Price $27
- Analysts Conflicted on These Healthcare Names: Insight Molecular Diagnostics (IMDX), Tandem Diabetes Care (TNDM) and Odyssey Therapeutics, Inc. (ODTX)
暂无评论——快来第一个聊聊 ODTX。
登录后参与讨论。